NAFLD:心血管疾病的新兴因果因素
Mei Li1, Hongmin Wang2, Xiao-Jing Zhang1,3,4
1School of Basic Medical Sciences, Wuhan University, Wuhan, China.
Physiology (Bethesda, Md.)
|July 11, 2023
概括
非酒精性脂肪性肝病 (NAFLD) 可能因果性地增加心血管疾病 (CVD) 风险. 本综述审查了将NAFLD与心血管疾病联系在一起的证据,突出了共同的风险因素和对管理这两种疾病的临床影响.
科学领域:
- 肝病学和心脏病学.
- 代谢综合征研究 代谢综合征研究
背景情况:
- 非酒精性脂肪肝 (NAFLD) 是一个全球性的健康问题.
- 心血管疾病 (CVD) 是NAFLD患者的主要死亡原因.
- 共同的危险因素包括肥胖,胰岛素抵抗和2型糖尿病.
研究的目的:
- 审查证据支持NAFLD和CVD之间的因果关系.
- 探索将NAFLD与心血管疾病发展联系在一起的机制.
- 强调对NAFLD和心血管疾病风险的综合管理.
主要方法:
- 对前性临床研究的分析.
- 孟德尔随机化研究的评价.
- 综合目前关于NAFLD-CVD病原学的研究.
主要成果:
- 有证据表明,NAFLD可能是心血管疾病的因果风险因素.
- 机制涉及共享的代谢途径和直接的肝心效应.
- 临床管理需要同时关注NAFLD患者的心血管疾病风险.
结论:
- 越来越多地承认NAFLD是心血管疾病的重要贡献者.
- 了解因果关系对于患者的治疗结果至关重要.
- 综合的临床策略对于有效的NAFLD和CVD管理至关重要.
更多相关视频
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
6.4K
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
3.6K
相关概念视频
Coronary Artery Disease I: Introduction
25
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
25
Coronary Artery Disease II: Pathophysiology
13
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
13
Atherosclerosis I: Introduction
11
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
11
Peripheral Artery Disease I: Introduction
10
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
10
Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13
Inflammation
53.9K
Overview
53.9K
